Doctors may use a special brain scan to help diagnose a condition called idiopathic normal pressure hydrocephalus (iNPH) in patients with MS and other diseases.
The study looked at brain scans of patients with iNPH, Alzheimer's disease (AD), and healthy people. It found that the choroid plexus (a part of the brain that makes fluid) was larger in iNPH patients compared to those with AD and healthy individuals. This is important because it means that doctors might be able to tell if someone has iNPH just by looking at this size difference in brain scans. The study also confirmed that the size of the choroid plexus and another brain area called the lateral ventricle were useful in making this diagnosis. Essentially, a bigger choroid plexus could help doctors figure out what's wrong more accurately.
This finding is significant for MS patients who may have symptoms similar to iNPH, like problems with movement or memory. Caregivers and family members can benefit by understanding why doctors might recommend certain brain scans and what the results could mean. If a doctor can diagnose iNPH early, patients may receive better treatment sooner, which could improve their daily lives. This could be like catching a problem early so it doesn't become a bigger issue later. Overall, knowing about these findings helps everyone involved in care to work better together.
The study only looked at a small number of patients, so more research is needed to confirm these results. Also, the focus was on iNPH, which is a different condition than MS, so the findings may not apply directly to MS itself. Patients and caregivers should discuss any concerns with their healthcare provider to understand how these results relate specifically to their situation.
12/1/2025
Learn how anti-NMDAR encephalitis overlaps with MS and what it means for treatment and symptom manag
Read More12/1/2025
Learn how the PHH-1V booster shot could provide better COVID protection for MS patients and their ca
Read More12/1/2025
Discover how dignity affects family caregivers of MS patients and why their feelings matter for bett
Read More12/1/2025
Learn how studying certain viral genes in our DNA may lead to better MS treatments and improve sympt
Read More12/1/2025
Discover how gut bacteria may boost cognitive function in MS patients and why gut health matters for
Read More12/1/2025
Discover how targeting Piezo1 in immune cells could change MS management and improve symptoms for pa
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.